Press Releases

23 05, 2018

Adarza Sets Stage for Commercialization

2018-05-23T15:01:45+00:00 May 23rd, 2018|

Adarza Biosystems, Inc., a biotechnology company developing a novel protein and biomolecule detection platform, announced today that it has put in place the leadership, new manufacturing center and branding to begin selling its technology to researchers in the second quarter of 2019.

19 01, 2017

ADARZA BIOSYSTEMS CLOSES ON $17 MILLION SERIES C FINANCING

2018-05-02T01:29:44+00:00 January 19th, 2017|

ROCHESTER, NY and ST LOUIS, MO (Jan. 19, 2017) – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development and commercialization of Adarza’s first immunoassay product consumable and instrument platform. Adarza develops and manufactures immunoassay technology that can identify proteins and genetic markers in medical samples such as blood. The technology, which comes in the form of microchips, [...]

24 03, 2016

Adarza BioSystems Completes $5 M Series-B Closing

2018-05-02T01:29:44+00:00 March 24th, 2016|

ROCHESTER, N.Y. ST LOUIS, MO – Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed a $5 M Series B financing. Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable and instrument platform. Proceeds will also be used to accelerate development of highly sensitive assays targeting a variety of biological analytes including cytokines, antigens and small molecules. Adarza’s Arrayed Imaging Reflectometry (AIRstrip™) will bring an unprecedented combination of performance, [...]

25 11, 2014

Horizon Discovery Group plc and Adarza BioSystems Enter Supply & Licensing Agreement

2018-05-02T01:29:44+00:00 November 25th, 2014|

Agreement gives Horizon exclusive right to supply services on Ardaza’s multiplex label-free immunoassay technology.

1 10, 2014

Adarza BioSystems Completes $6.8M Series-A Financing

2018-05-02T01:29:45+00:00 October 1st, 2014|

ROCHESTER, NY:  Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed the final tranche of its Series-A financing bringing the total Series-A financing amount to $6.8 million. Proceeds from the financing will be used to launch its first 100-plex immunoassay product consumable and instrument and accelerate development of higher plex highly sensitive assays targeting a variety of biological analytes. Adarza’s Arrayed Imaging Reflectometry (AIR-StripTM) will bring an unprecedented combination of performance and workflow benefits with high sensitivity, broad dynamic range, precision and assay robustness to [...]

17 04, 2013

BioGenerator Investment Helps Adarza BioSystems Establish Operations in St. Louis

2018-05-02T01:29:45+00:00 April 17th, 2013|

Life Science company expands presence to St. Louis ST. LOUIS, MO:  BioGenerator recently led syndication of investment in Adarza BioSystems, Inc., to support further commercialization of the company’s immunoassay products. As part of the investment, Adarza will conduct its primary business and product development in St. Louis as well as its manufacturing activities. Adarza is a next-generation multiplex immunoassay product company focused on applications in life science tools and the in vitro diagnostics markets. Multiplex technology allows researchers to explore the regulation of many different targets simultaneously. Adarza’s products and services utilize its proprietary [...]

4 02, 2013

Adarza BioSystems Awarded Federal Grant to Support Toxic Exposure Assessment Product Development

2018-05-02T01:29:45+00:00 February 4th, 2013|

ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $245,912 Small Business Innovation Research (SBIR) grant from the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) to aid the company in its efforts to apply its breakthrough Arrayed Imaging Reflectometry (AIRTM) bioassay platform for the detection of environmental toxins in a small quantity of blood. The SBIR program is a highly competitive program that encourages domestic small businesses to engage in Federal Research/Research and Development (R/R&D) that has the potential for commercialization. Through a competitive awards-based program, SBIR enables [...]

1 09, 2009

Adarza Biosystems Awarded Phase II SBIR Grant to Support Environmental Exposure Assessment Product Development

2018-05-02T01:29:45+00:00 September 1st, 2009|

ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $1.8 million Small Business Innovation Research (SBIR) grant from the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) to aid the company in its efforts to apply its breakthrough Arrayed Imaging Reflectometry (AIRTM) bioassay platform for the detection of blood proteins indicative of an individual’s physiological reaction to environmental toxins such as airborne particulate matter. The SBIR program is a highly competitive program that encourages domestic small businesses to engage in Federal Research/Research and Development (R/R&D) that has the [...]